COLGALT2 and ovarian carcinoma: Guo et al. found that PLOD3 is associated with ovarian cancer tumor progression and demonstrated that the interaction of COLGALT2 and PLOD3 can enhance the invasiveness of ovarian cancer (Guo et al., 2021b).